Deciphera Pharmaceuticals Receives $75,604,034 New Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=93aa15dc-4d7f-4579-9c7e-adfce78ea4db
Date
7/15/2016
Company Name
Deciphera Pharmaceuticals
Mailing Address
1601 Trapelo Road Waltham, MA 02451 USA
Company Description
Deciphera Pharmaceuticals, LLC was established in 2003 as a drug discovery and development company with the mission to design, optimize and introduce best-in-class small molecule switch inhibitors of protein kinases for human clinical trials and the global pharmaceutical marketplace through the use of its proprietary drug discovery technology platform.
Website
http://www.deciphera.com
Transaction Type
Venture Equity
Transaction Amount
$75,604,034
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. 5 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed